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ABSTRACT Indoor air pollution (IAP) or environmental tobacco smoke (ETS) exposure may influence
nasopharyngeal carriage of bacterial species and development of lower respiratory tract infection (LRTI).
The aim of this study was to longitudinally investigate the impact of antenatal or postnatal IAP/ETS
exposure on nasopharyngeal bacteria in mothers and infants.
A South African cohort study followed mother–infant pairs from birth through the first year.
Nasopharyngeal swabs were taken at birth, 6 and 12 months for bacterial culture. Multivariable and
multivariate Poisson regression investigated associations between nasopharyngeal bacterial species and
IAP/ETS. IAP exposures (particulate matter, carbon monoxide, nitrogen dioxide, volatile organic
compounds) were measured at home visits. ETS exposure was measured through maternal and infant
urine cotinine. Infants received the 13-valent pneumococcal and Haemophilus influenzae B conjugate
vaccines.
There were 881 maternal and 2605 infant nasopharyngeal swabs. Antenatal ETS exposure was associated
with Streptococcus pneumoniae carriage in mothers (adjusted risk ratio (aRR) 1.73 (95% CI 1.03–2.92))
while postnatal ETS exposure was associated with carriage in infants (aRR 1.14 (95% CI 1.00–1.30))
Postnatal particulate matter exposure was associated with the nasopharyngeal carriage of H. influenzae
(aRR 1.68 (95% CI 1.10– 2.57)) or Moraxella catarrhalis (aRR 1.42 (95% CI 1.03–1.97)) in infants.
Early-life environmental exposures are associated with an increased prevalence of specific
nasopharyngeal bacteria during infancy, which may predispose to LRTI.
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Nasopharyngeal microbiota, comprised of a myriad of microorganisms, is rapidly acquired after birth and
established in infancy [1, 2]. Nasopharyngeal carriage of potentially pathogenic bacteria in early life
precedes the development of lower respiratory tract infections (LRTIs) including pneumonia and
bronchiolitis [3]. Understanding the factors that impact on nasopharyngeal carriage may therefore be
important in developing strengthened strategies to prevent LRTIs, a major cause of death in children in
low and middle-income countries (LMICs).
Nasopharyngeal carriage may be influenced by several environmental factors including exposure to
environmental tobacco smoke (ETS) or indoor air pollution (IAP) [4]. Rapid urbanisation particularly in
LMIC, has resulted in an increased use of alternate fuel sources for household energy, with numerous
by-products of combustion (including particulate matter (particulate matter <10 μm in diameter (PM10)),
carbon monoxide (CO), nitrogen dioxide (NO2) and volatile organic compounds (VOCs)) contributing to
IAP [5]. Antenatal and early-life exposure to ETS has many potentially detrimental effects on child health
including an increased incidence and severity of LRTIs [6, 7].
While studies have assessed the effect of household air pollution on the lung microbiome [8], no studies
have investigated the effects of IAP on nasopharyngeal carriage, particularly in infants. However, recently
mouse models have shown black carbon (a component of particulate matter) induced structural,
compositional and functional changes in bacterial biofilms and their responses to antibiotics as well as
facilitated the micro-aspiration of Streptococcus spp. from the nasopharynx to the lung [9]. Further, ETS
exposure increases the nasopharyngeal carriage of Streptococcus pneumoniae [10], alters innate immune
mechanisms in the nasal mucosa and disrupts epithelial barriers [11].
This study longitudinally investigated the impact of antenatal and postnatal IAP and ETS exposure on
nasopharyngeal carriage in mothers and infants enrolled in an African birth cohort study, from birth to
1 year of age.
Methods
Study population and procedures
This study was nested within the Drakenstein Child Health Study (DCHS), a birth cohort in a peri-urban
area of South Africa [12]. Consenting pregnant women were enrolled at 20–28 weeks’ gestation at two
public primary health clinics: Mbekweni (serving a predominantly black African population) and Newman
(serving a predominantly mixed ancestry population) from March 2012 to July 2015.
All births occurred at a single, central hospital, Paarl hospital. Thereafter, mother–infant pairs were
followed at 6, 10 and 14 weeks, 6, 9 and 12 months, for healthcare and immunisations including the
13-valent pneumococcal conjugate vaccine (PCV-13) given at 6, 14 weeks and 9 months and Haemophilus
influenzae type b conjugate vaccine at 6, 10, 14 weeks according to the South African Expanded
Programme on Immunisation schedule [13]. Study questionnaires and clinical data were collected at
enrolment and follow-up visits. A validated socioeconomic score (SES) was used to categorise participants
into quartiles as lowest, low-moderate, moderate-high or highest SES [5]. Clinical data collected at each
follow-up visit included details on recent respiratory tract infections, including respiratory symptoms, otitis
media, wheeze or LRTIs in the preceding month and any antibiotic use in the prior 6 months.
Assessing environmental exposures
Measuring IAP exposure
The participant’s home environment was assessed and dwellings categorised based on having two or more
defined household dimensions (type of home, building material, water supply, toilet facilities, kitchen type,
ventilation in kitchen areas) [5]. IAP was measured at home visits conducted antenatally (within 4 weeks
of enrolment) and postnatally (between 4–6 months of the infant’s life) [5]. Home visits were conducted
over 3 years with sampling occurring throughout the year covering all seasons and weather conditions.
PM10 and CO were measured by separate monitors (AirChek 52; SKC, Eighty-Four, PA, USA for PM10
and Altair; Troy, MI, USA for CO) left in homes over 24 h. NO2 and VOCs, benzene and toluene, were
measured using diffusion tubes (Radiello absorbent filters in polyethylene diffusive body; Sigma-Aldrich,
St Louis, MO, USA) and (Markes thermal desorption tubes; Llantrisant, UK) left in homes for 2 weeks [5].
These monitors were internally calibrated for temperature and humidity as per the manufacturer
information, whereas diffusion tubes were corrected for humidity during laboratory analysis [5, 14]. The
South African National Ambient Air Quality Standards were used to define expected exposure levels for
each pollutant based on an averaging period of 1 year for each measure [15, 16].
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Measuring ETS exposure
Maternal, paternal and household tobacco smoking and exposure were assessed using questionnaires
administered at enrolment, and antenatal and postnatal visits. These were validated using maternal and
infant urine cotinine measures. Maternal cotinine was measured antenatally and at birth, and infant
cotinine at birth and 6–10 week with the highest result used to assign smoking status and exposure.
Cotinine levels were classified as <10 ng·mL−1 (nonsmoker), 10–499 ng·mL−1 (passive smoker/exposed),
or ⩾500 ng·mL−1 (active smoker) [7].
Assessing nasopharyngeal carriage of bacteria
Nasopharyngeal swabs were obtained from mothers (at the time of delivery) and infants at birth, 6 and
12 months by trained study staff according to World Health Organization recommendations [17]. The
swabs were immediately stored in 1 mL of skimmed milk, tryptone, glucose and glycerol transport
medium (STGG), transported on ice to the laboratory and frozen at −80°C for later batch processing.
After thawing at room temperature (22°C), samples were vortexed for 15 s before plating out a 10 µL
aliquot onto four different solid media (National Health Laboratory Services, Green Point Media
Laboratory Cape Town, South Africa). Standard laboratory protocols were used for the phenotypic and
biochemical identification of common bacterial species that asymptomatically colonise the upper
respiratory tract. For S. pneumoniae culture, Columbia blood agar base with 2% agar, 5% horse blood and
4 mg·mL−1 gentamicin (CAG) was incubated at 37°C in 5% CO2 overnight. Presumptive S. pneumoniae
isolates were identified by colony morphology, α-haemolysis, optochin disk susceptibility (Oxoid,
Basingstoke, UK) and confirmed using lytA PCR [18]. For H. influenzae, bacitracin heated blood agar
plates were incubated at 37°C with 5% carbon dioxide (CO2). Suspected H. influenzae colonies were
inoculated onto Columbia agar and identified using Factors X, V and XV discs and by observing growth
in the haemolytic zone of Staphylococcus aureus on blood agar plates. S. aureus isolates were identified by
culturing on mannitol salt agar, and DNase testing whereas Moraxella catarrhalis isolates were identified
by culturing on 2% blood agar and incubated overnight at 37°C. Isolates were presumptively identified by
push test and confirmed by copB PCR [19]. Gram-negative bacteria were subcultured onto MacConkey
agar and identified on Vitek 2® (bioMérieux, Marcy I’Etoile, France).
Ethics
The study was approved by the Human Research Ethics Committees of the Faculties of Health Sciences,
University of Cape Town and Stellenbosch University, and by the Western Cape Provincial Health
Research committee (HREC 149/2013). Mothers provided written informed consent at enrolment.
Statistical analysis
Study data were captured in a relational Microsoft Access® database or collected and managed using
REDCap electronic data capture tools hosted at the University of Cape Town [20]. Statistical analyses were
conducted in Stata version 14.2 for Windows (Stata Corp, College Station, TX, USA). Statistical tests were
considered significant if the p-value was <0.05 or if p-value cut-offs were derived using the
Benjamini–Hochberg procedure for assessing the association between IAP and the pathogens [21].
Categorical variables were summarised using frequency counts and percentages, n (%). Normally and
non-normally distributed continuous variables were described using mean (SD) and median (interquartile
range (IQR)) values, respectively. Mann–Whitney or Wilcoxon signed-rank tests, as appropriate, were used
to compare medians as well as their spread. Cross tabulations with Fishers’ exact or Chi-squared tests were
used to describe and compare the prevalence of pathogen carriage between the infants (at all time points)
and their mothers or between different time points for infants.
Multivariable modified Poisson regression analyses with robust error variance [22] were performed to
estimate adjusted risk ratios (aRRs) between each bacterial pathogen and IAP measures (individually
(adjusted) or together (adjusted 2)). The association between antenatal exposures or maternal cotinine and
maternal carriage was explored as was the association between postnatal exposure or infant cotinine and
infant carriage. The multivariable Poisson regressions adjusted for demographic and clinical factors
(weight-for-age z-score at birth, preterm, ethnicity, sex, HIV exposure, time on exclusive breastfeeding,
average number of people per sleeping room, dwelling category, recent respiratory infection, day care
attendance, vaccination, number of other children under 5 years in the household, antibiotic use) that have
been associated with pathogen acquisition. Multivariable regressions were then further performed for each
site [23, 24]. Further, we explored the possible confounding effects of bacterial co-carriage by including
indicator variables for each pathogen.
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Results
During the study period there were 1137 women enrolled with 1143 live births (four sets of twins and one
set of triplets), of which 986 infants had at least one IAP home measurement and one nasopharyngeal
swab collected and were included in this analysis (figure 1).
Maternal characteristics
A total of 530 (54%) mothers were enrolled from Mbekweni (a predominantly black African population) and
452/982 (46%) from Newman (predominantly mixed ancestry). The median age of mothers enrolled was
25.8, IQR (22.0, 30.6) years. Significantly more Mbekweni mothers were HIV-infected; 193 (36%) compared
with Newman, 13 (3%), p<0.001. However, with an effective prevention of mother-to-child transmission
programme only two infants (<1%) were HIV-infected. Unemployment was high in both communities (74%)
with more Mbekweni participants in the lowest SES (30%) compared with Newman (18%; table 1).
Infant characteristics
Of the 986 infants included, 484 (49%) were female; the median gestational age was 39 (IQR 38, 40)
weeks. Most (585 (59%)) infants were not breastfed at 6 months and duration of exclusive breastfeeding
was 1.4 (IQR 0.7, 3.0) months. Significantly more Newman infants attended day care at both 6 months
(6%) and 12 months (20%) of age compared with Mbekweni infants; 6 months (3%) and 12 months (5%).
In 851 (86%) of households there was at least one other child younger than 5 years. Overall, 77 (8%)
children reported a recent respiratory infection at 6 months and 51 (5%) at 12 months of age. Antibiotic
use was infrequent, (table 1), while vaccine coverage was high in infants (supplemental table 1).
Home environment and exposures
Almost 40% of homes were informal and one-third of homes had less than two of the defined household
dimensions. Electricity access was high (95%); however, nearly one-third of Mbekweni homes used
alternate fuels for cooking and heating. The median Mbekweni household size was 4 (IQR 3–6) people,
smaller than Newman at 5 (IQR 4–7) people (table 2)
Of the pollutants measured antenatally, significantly more Mbekweni homes had NO2 levels above
ambient standard compared with Newman (16 (4%) versus 3 (1%)); overall, 45% of homes had measured
benzene levels above ambient standards. However, none of the median levels were above ambient
standards. For pollutants measured postnatally, there were significant differences across sites in prevalence
of above ambient standards for NO2 (p=0.041) and CO (p=0.026; table 2).
Using maternal cotinine measures, 316 (33%) of mothers were active smokers, significantly higher for
Newman, 241 (55%) compared with Mbekweni, 76 (15%) and a further 423 (44%) were exposed to
tobacco smoke. For infant ETS exposure, 524 (69%) had cotinine levels indicative of tobacco smoke
exposure, of which 104 (14%) were that of a level of active smokers (table 2).
Nasopharyngeal bacterial carriage
At delivery, 167/881 (19%; 95% CI 16–22) mothers carried S. aureus, 114/881 (13%; 95% CI 11–15)
S. pneumoniae, 57/881 (6%; 95% CI 5–8) H. influenzae, 59/881 (7%; 95% CI 5–9) Moraxella catarrhalis





157 with no IAP
measure or samples
collected
986 with any IAP
measure (604 with both, 
259 with antenatal only
and 123 with postnatal 
only)
FIGURE 1 Cohort description and samples collected. IAP: indoor air pollution.
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At birth, 15/911 (2%; 95% CI 1–4) infants had S. aureus while 40/911 (4%; 95% CI 3–6) had
gram-negative bacilli on nasopharyngeal samples. By 6 months, 584/887 (66%; 95% CI 63–69) infants
carried S. pneumoniae, which remained the predominant organism at 1 year of age, carried by 547/800
(68%; 95% CI 65–72). However, carriage of S. aureus 53/800 (7%; 95% CI 6–9) or gram-negative bacilli
18/800 (2%; 95% CI 1–4) decreased between 6 and 12 months (p<0.001). The median number of bacteria
carried was two (IQR 1–3) and two (IQR 1–2) at 6 and 12 months respectively (figure 2).
Of the infants who carried H. influenzae at 6 months, 160 (50%) continued to carry this at 12 months.
Likewise, 376 (74%) of infants who carried S. pneumoniae at 6 months also carried S. pneumoniae at
12 months (supplemental table 2).
Associations between environmental exposures and nasopharyngeal carriage
Antenatal exposures and maternal nasopharyngeal carriage
Antenatal exposure to NO2 above ambient standards was associated with increased maternal
nasopharyngeal carriage of M. catarrhalis when adjusted for all clinical covariates (adjusted; aRR 3.65
(95% CI 1.39–9.58)) and when adjusted for clinical covariates as well as the other pollutants (adjusted 2;
aRR 3.69 (95%CI 1.27–10.73)).
Benzene exposure was associated with maternal H. influenzae carriage when adjusted for clinical covariates
(adjusted; aRR 2.06 (95% CI 1.18–3.59)) and tobacco smoke exposure almost doubled the risk of
S. pneumoniae carriage in mothers (aRR 1.73 (95% CI 1.03–2.92)) (figure 3).
TABLE 1 Maternal and infant characteristics
Mbekweni (black African) Newman (mixed ancestry) Total p-value
Maternal characteristics
Mothers 530 (54%) 452 (46%) 982 (100%)
Age at enrolment years 26.9 (22.3, 31.6) 24.6 (21.3, 29.1) 25.8 (22.0, 30.6) <0.001
HIV-infected 193 (36%) 13 (3%) 206 (21%) <0.001
Unemployed 400 (75%) 325 (72%) 724 (74%) 0.205
SES quartile
Lowest SES 157 (30%) 80 (18%) 237 (24%) <0.001
Low–moderate SES 150 (28%) 109 (24%) 259 (26%)
Moderate–high SES 126 (24%) 127 (28%) 253 (26%)
Highest SES 97 (18%) 136 (30%) 233 (24%)
Household members 4 (3, 6) 5 (4, 7) 4 (3, 6) <0.001
Married/cohabiting 188 (35%) 194 (43%) 382 (39%) 0.017
Infant characteristics and birth outcomes
Number of infants; sets of twins 534 (54%); 4 452 (46%); 0 986 (100%); 4
Female 280 (52%) 204 (45%) 484 (49%) 0.022
Gestation at delivery weeks 39 (38, 40) 39 (37, 40) 39 (38, 40) 0.032
Birthweight g 3180 (2810, 3460) 2990 (2630, 3340) 3080 (2720, 3415) <0.001
Weight-for-age z-score −0.4 (−1.3, 0.2) −0.7 (−1.4, −0.1) −0.6 (−1.3, 0.0) <0.001
Birthweight <2500 g 55 (10%) 83 (18%) 138 (14%) <0.001
Birth <37 weeks gestation 16 (3%) 19 (4%) 35 (4%) 0.314
Feeding at 6 months
Exclusive breastfeeding 76 (14%) 66 (15%) 142 (14%) <0.001
Mixed 89 (17%) 170 (38%) 259 (26%)
Not breastfeeding 369 (69%) 216 (48%) 585 (59%)
Duration of exclusive breastfeeding months 1.1 (0.5, 3.0) 1.6 (0.9, 3.0) 1.4 (0.7, 3.0) 0.410
Day care attendance
6 months of age 17 (3%) 28 (6%) 45 (5%) 0.024
12 months of age 69 (13%) 90 (20%) 159 (16%) 0.003
Additional child under 5 years of age in household 455 (85%) 396 (88%) 851 (86%) 0.274
Respiratory infection in prior month
6 months of age 40 (7%) 37 (8%) 77 (8%) 0.685
12 months of age 29 (5%) 22 (5%) 51 (5%) 0.691
Antibiotic use in prior 6 months
6 months of age 25 (5%) 38 (8%) 63 (6%) 0.057
12 months of age 14 (3%) 13 (3%) 27 (3%) 0.957
Data are presented as median (interquartile range), unless otherwise stated. SES: socioeconomic score.
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Site-specific multivariable analysis generally showed similar associations. Mbekweni showed gram-negative
bacilli carriage being associated with toluene (aRR 5.92 (95% CI 1.16–30.08); supplemental table 3). For
Newman, smoking also increased the risk of gram-negative bacilli carriage exponentially (supplemental
table 4).
Postnatal exposures and infant nasopharyngeal carriage
PM10 was associated with an increased risk of H. influenzae at 6 months (adjusted 2; aRR 1.68 (95% CI
1.10–2.57)) and M. catarrhalis at 12 months (adjusted 2; aRR 1.42 (95% CI 1.03–1.97)), while NO2
increased the risk of gram-negative bacilli carriage at 12 months (adjusted; aRR 15.89 (95% CI 3.35–75.46);
table 3). Further, when adjusting for co-carriage, clinical covariates and all the other pollutants (adjusted 2),
PM10 was still associated with an increased risk of H. influenzae at 6 months, (aRR 1.60 (95% CI
1.04–2.46)) and M. catarrhalis at 12 months (aRR 1.39 (95% CI 1.02–1.90)), and NO2 with gram-negative
TABLE 2 Home environment and exposures
Mbekweni Newman Total p-value
Home environment
Household dimensions#
Has ⩽2 dimensions 185 (38%) 121 (27%) 306 (33%) <0.001
Has >2 dimensions 302 (62%) 320 (73%) 622 (67%)
Alternate fuel used (coal, wood, paraffin, gas)
Cooking 133 (31%) 37 (10%) 170 (21%) <0.001
Heating 127 (29%) 7 (2%) 134 (16%) <0.001
Crowding
Household size 4 (3, 6) 5 (4, 7) 4 (3, 6) <0.001
Persons per sleeping room 3 (2, 4) 3 (2, 5) 3 (2, 5) 0.010
Pollutants measured: antenatal
PM10 g·m−3 (n=755) 32.0 (12.3, 64.2) 35.6 (12.8, 65.6) 33.4 (12.4, 65.6) 0.417
Above threshold 73 (19%) 65 (18%) 138 (18%) 0.853
NO2 µg·m
−3 (n=747) 7.3 (2.6, 14.6) 7.1 (3.9, 11.3) 7.1 (3.4, 12.7) 0.494
Above threshold 16 (4%) 3 (1%) 19 (3%) 0.005
Benzene µg·m−3 (n=729) 4.6 (1.5, 17.9) 3.9 (1.8, 8.6) 4.3 (1.8, 11.0) 0.475
Above threshold 183 (47%) 147 (43%) 330 (45%) 0.244
Toluene µg·m−3 (n=729) 16.1 (5.9, 43.0) 17.4 (8.2, 46.5) 16.9 (7.2, 44.6) 0.282
Above threshold 36 (9%) 30 (9%) 66 (9%) 0.803
CO mg·m−3 (n=706) 0.0 (0.0, 5.1) 0.0 (0.0, 8.4) 0.0 (0.0, 7.6) 0.144
Above threshold 39 (10%) 42 (14%) 81 (11%) 0.095
Pollutants measured: postnatal
PM10 g·m−3 (n=505) 30.0 (14.7, 49.7) 28.4 (10.5, 53.7) 29.3 (12.6, 52.5) 0.364
Above threshold 38 (16%) 36 (14%) 74 (15%) 0.499
NO2 µg·m
−3 (n=532) 6.3 (2.9, 14.6) 5.3 (2.6, 11.3) 5.8 (2.6, 12.67) 0.119
Above threshold 6 (2%) 1 (0%) 7 (1%) 0.041
Benzene µg·m−3 (n=462) 2.8 (0.8, 14.4) 3.2 (1.5, 7.6) 3.1 (1.1, 9.5) 0.345
Above threshold 95 (39%) 75 (35%) 170 (37%) 0.426
Toluene µg·m−3 (n=462) 15.1 (4.9, 50.0) 15.9 (6.5, 51.7) 15.5 (5.9, 50.0) 0.342
Above threshold 24 (10%) 23 (11%) 47 (10%) 0.728
CO mg·m−3 (n=502) 0.0 (0.0, 0.0) 0.0 (0.0, 5.6) 0.0 (0.0, 0.0) 0.018
Above threshold 17 (7%) 30 (12%) 47 (9%) 0.026
Maternal antenatal tobacco smoking
Number of mothers 530 451 981
Maternal urine cotinine (n=954) 512 442
<10 ng·mL−1, non-smoker 181 (35%) 47 (11%) 228 (24%) <0.001
10–499 ng·mL−1, passive/exposed 255 (50%) 155 (35%) 410 (43%)
⩾500 ng·mL−1, active smoker 76 (15%) 240 (54%) 316 (33%)
Infant urine cotinine
Urine cotinine at birth or 6–10 weeks (n=763) 415 348
<10 ng·mL−1 184 (44%) 55 (16%) 239 (31%) <0.001
10–499 ng·mL−1 212 (51%) 208 (60%) 420 (55%)
⩾500 ng·mL−1 19 (5%) 85 (24%) 104 (14%)
Data are presented as median (interquartile range), unless otherwise stated. PM10: particulate matter <10 μm in diameter; NO2: nitrogen
dioxide; CO: carbon monoxide. #: dimensions comprise type of home, building material, water supply, toilet facilities, kitchen type and
ventilation in kitchen areas.
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bacilli at 12 months (adjusted; aRR 9.44 (95% CI 1.96–45.40)) while CO increased the risk of
S. pneumoniae carriage at 6 months (aRR 1.33 (95% CI 1.03–1.72); supplemental table 7).
In infants, ETS exposure was also associated with an increased risk of S. pneumoniae carriage at 6 months
of age (aRR 1.14 (95% CI 1.00–1.30); adjusted; table 3) The association between smoke exposure and
S. pneumoniae was also noted when adjusting for the other bacterial organisms co-carried (adjusted; aRR
1.16 (95% CI 1.02–1.32) at 6 months (supplemental table 7).
Site-specific analysis showed similar risks for Mbekweni with PM10 increasing the risk of H. influenzae (aRR
2.09 (95% CI 1.15–3.81)) carriage and NO2 gram-negative bacilli (aRR 3.88×10
8 (95% CI 1.32×108 to 1.14×109);
supplemental table 5). However, for Newman, NO2 was associated with an increased risk of S. pneumoniae
carriage at both 6 months (aRR 2.66 (95% CI 2.04–3.47)) and 12 months (aRR 1.75 (95% CI 1.26–2.42)).
Also of note for Newman, was that the VOCs (benzene and toluene) were associated with an increased
risk of H. influenzae carriage at 6 months (adjusted; aRR 1.45 (95% CI 1.06–2.00)) and S. pneumoniae
carriage at 12 months (adjusted 2; aRR 1.31 (95% CI 1.06–1.60)) respectively (supplemental table 6).
Discussion
In this large peri-urban birth cohort study, we have shown an association between antenatal IAP exposure
and maternal nasopharyngeal carriage of bacteria and the impact of tobacco smoke exposure on both
maternal and infant bacterial carriage, particularly S. pneumoniae. We also report an association between
exposure to other indoor air pollutants including PM10, NO2 and CO on infant bacterial nasopharyngeal
carriage. Further, despite the socioeconomic and ethnic differences between the two communities studied,
the environmental risks associated with carriage were similar.
While it is recognised that several factors including age, season, day care, number of siblings, acute
respiratory illness, HIV infection, diet and vaccination may influence the acquisition of nasopharyngeal
carriage in infants [4, 23]. the effect of IAP on nasopharyngeal carriage has not been well described
particularly in LMICs [25]. In this study, significant associations between exposure to several IAP and





















































FIGURE 2 Nasopharyngeal bacterial carriage at birth, 6 months and 1 year of life.
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associated with carriage and for co-carriage. The associations noted between postnatal PM10 exposure and
infant H. influenzae and M. catarrhalis carriage were consistent. It is well recognised that PM10 exposure is
associated with LRTIs and childhood respiratory diseases [26–28]. Further, an in vitro study found that
PM10 promoted bacterial invasion of epithelial airway cells by attenuating innate defence mechanisms,
through the disruption of human defensins, a critical part of antimicrobial activity [29]. Black carbon, a
component of PM10, has also been shown to impact bacterial colonisation as well as spread of bacteria
from the nasopharynx to the lungs [9]. In this cohort, we have also previously shown an association
between PM10 exposure and LRTIs in infancy [30]. However, the inclusion of nasopharyngeal swab
sampling at only two time points (6 and 12 months) in this study, precluded a longitudinal analysis of the
impact of bacterial carriage on LRTIs. Nevertheless, this finding highlights the impact of IAP exposure in
several ways that may contribute to child respiratory illness. Although there were no consistent
associations between postnatal IAP exposure and infant carriage at 6 and 12 months, this may reflect both
the dynamic nature of bacterial carriage and the complex interplay of a number of factors that influence
this and highlights the importance of IAP and ETS exposure in influencing nasopharyngeal bacterial
carriage. Also of note was although there were differences between the communities studied, IAP exposure
and the risks associated with bacterial carriage were similar. However, interestingly in the community of
mixed ethnicity, postnatal VOC exposure from benzene and toluene significantly increased the risk of
bacterial carriage of a number of organisms. VOCs are a by-product of combustion of alternate fuels such
as paraffin and cigarette smoke [31] and may also reflect the much higher prevalence of maternal smoking
and exposure in this population compared with the black African community.
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FIGURE 3 Multivariate analysis of antenatal exposures and maternal nasopharyngeal bacterial carriage. PM10: particulate matter <10 µm in
diameter; RR: risk ratio.
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TABLE 3 Multivariate analysis of postnatal exposures and infant nasopharyngeal bacterial carriage
S. aureus S. pneumoniae H. influenzae M. catarrhalis Gram negative bacilli
Adj Adj2 Adj Adj2 Adj Adj2 Adj Adj2 Adj Adj2
PM10
6 months 0.98 (0.57–1.70) 0.95 (0.42–2.14) 0.96 (0.79–1.16) 0.96 (0.69–1.34) 1.09 (0.85–1.40) 1.68 (1.10– 2.57) 0.91 (0.70–1.18) 0.88 (0.57–1.35) 0.61 (0.19–1.95) 0.13 (0.02–1.05)
12 months 0.56 (0.13–2.48) 2.23 (0.40–12.35) 1.02 (0.87–1.20) 0.98 (0.72–1.35) 1.15 (0.88–1.51) 1.09 (0.69–1.73) 1.12 (0.90–1.40) 1.42 (1.03–1.97) 0.92 (0.11–7.59)
NO2
6 months 0.90 (0.16–4.93) 2.15×10−6
(1.39×10−7–
3.32×10−5)





















6 months 0.78 (0.52–1.17) 0.78 (0.33–1.83) 1.01 (0.87–1.17) 0.88 (0.64–1.22) 0.96 (0.77–1.19) 1.68 (1.10–2.57) 0.95 (0.48–1.20) 1.00 (0.72–1.39) 0.65 (0.30–1.42) 0.38 (0.13–1.09)
12 months 0.81 (0.36–1.82) 1.37 (0.20–9.59) 1.01 (0.89–1.15) 1.17 (0.90–1.51) 0.83 (0.65–1.05) 0.90 (0.55–1.46) 0.89 (0.74–0.09) 0.92 (0.66–1.28) 2.06 (0.44–9.74)
CO
6 months 1.17 (0.74–1.87) 1.53 (0.78–2.98) 1.03 (0.88–1.21) 1.28 (0.99–1.66) 1.03 (0.80–1.33) 0.99 (0.63–1.54) 1.04 (0.85–1.27) 1.19 (0.88–1.60) 1.15 (0.48–2.75) 2.15 (0.90–5.12)
12 months 0.68 (0.22–2.12) 0.56 (0.08–3.97) 1.05 (0.91–1.22) 1.13 (0.89–1.44) 1.01 (0.76–1.34) 0.91 (0.58–1.43) 0.98 (0.79–1.22) 1.01 (0.75–1.35) 1.60 (0.38–6.72)
Smoking
6 months 1.28 (0.87–1.88) 0.90 (0.44–1.83) 1.14 (1.00–1.30) 1.12 (0.86–1.47) 0.93 (0.75–1.15) 0.92 (0.62–1.37) 1.01 (0.84–1.22) 1.15 (0.81–1.62) 0.88 (0.46–1.70) 0.93 (0.34–2.62)
12 months 0.79 (0.42–1.50) 0.81 (0.18–3.58) 1 (0.87–1.15) 0.93 (0.74–1.18) 1.21 (0.96–1.53) 1.43 (0.95–2.17) 1.03 (0.87–1.21) 1.05 (0.77–1.41) 6.77 (0.91–50.53)
Toluene
6 months 0.55 (0.24–1.27) 0.86 (0.23–3.17) 0.95 (0.74–1.22) 1.23 (0.82–1.83) 0.88 (0.61–1.27) 0.52 (0.25–1.09) 0.99 (0.73–1.35) 5.57×10−7
(3.22×10−7–
9.64×10−7)
12 months 0.82 (0.22–3.04) 1.00×10−7
(1.95×10−7–
5.16×10−7)
1.1 (0.90–1.34) 1.00 (0.70–1.43) 1.15 (0.83–1.59) 1.14 (0.62–2.11) 1.13 (0.85–1.51) 5.84×10−7
(2.08×10−7–
1.64×10−6)
Data are presented as risk ratio (95% CI). Adj: adjusted for all the clinical-demographic variables; Adj2: adjusted for all the clinical-demographic variables, plus adjusting for other
indoor air pollutants. Risk ratios in bold are statistically significant at p-values derived using Benjamini–Hochberg (p<0.05). Empty cells indicate that model convergence was not























In this cohort, maternal smoking and infant in utero and postnatal tobacco exposure was very high as
indicated by urine cotinine in both mothers and infants. The high rates of maternal smoking especially
among mothers of mixed ethnicity is concerning, as is the very high exposure to household smoke from
both fathers and other household members [7]. ETS exposure was associated with an increased carriage of
several bacteria in mothers and infants including S. pneumoniae, S. aureus and gram-negative bacilli.
Nasopharyngeal carriage is recognised as a precursor to LRTIs and a source of person-to-person
transmission among individuals [3, 32]. Mice models have shown cigarette smoke suppressed nasal
inflammatory mediator expression, in particular neutrophil recruiting chemokines normally activated by
S. pneumoniae carriage, thereby predisposing to invasive S. pneumoniae infection. Further, smoking
cessation reversed this and prevented invasive pneumococcal disease [33]. Other animal studies have also
shown an increased neutrophil response to H. influenzae in cigarette-exposed mice, with interleukin 1α
produced by alveolar macrophages driving this process. This exaggerated response may underlie accelerated
lung pathology seen when there is cigarette smoke and bacterial infection [34]. Tobacco smoke also has
significant effects on the generation of adaptive immune responses to H. influenzae which may predispose
to recurrent infections and exacerbations particularly in chronic lung diseases [35]. The host’s ability to
control bacterial colonisation of the upper airway is also impacted by cigarette smoke with increased
inflammatory mediators and reduced blood granulocyte and monocyte phagocytosis activity [36]. These
mechanisms may therefore increase the risk of developing LRTIs and warrant further investigation.
The association between S. pneumoniae nasopharyngeal carriage and the development of subsequent
S. pneumoniae disease including LRTIs is well recognised [3, 32, 37]. Increased S. pneumoniae carriage in
infants associated with both CO and ETS exposure suggests that reducing exposure to these pollutants
could play a role in the prevention of childhood LRTIs. Further, tobacco smoke exposure almost doubled
maternal nasopharyngeal pneumococcal carriage, providing a source for increased transmission between
individuals. While we found no association between preceding or recurrent respiratory tract infection
(either upper or LRTIs), on nasopharyngeal bacterial carriage, the association between nasopharyngeal
pneumococcal carriage and the development of LRTIs (as an outcome) was not explored, as for this study
infant nasopharyngeal carriage was assessed only at two time points (6 and 12 months) and the majority of
LRTI cases occurred early, before 6 months [30]. Similarly, we were unable to assess the effect of 13-valent
pneumococcal conjugate vaccine (PCV13) (administered at 6, 14 weeks and 9 months) on S. pneumoniae
carriage due to the very high vaccination rates and the infrequent sampling period in this study. We have
however, previously described the association between IAP and ETS exposure and LRTIs in this cohort
[30], highlighting the role of IAP and ETS as potential risk factors for childhood respiratory illness.
The patterns of infant carriage seen in this cohort are consistent with those previously described, with
S. aureus predominating in the first months, followed by S. pneumoniae which persisted until 12 months
of age [23, 38]. The predominant maternal bacterium carried was S. aureus, however the prevalence was
lower than other studies which have reported maternal S. aureus carriage of up to 50% [39–41]. The high
rates of infant S. pneumoniae carriage are also consistent with those reported in low and
low-middle-income settings [37, 42]. The study extends this knowledge by identifying factors associated
with acquisition which have not previously been described in infants. A limitation of this study is reliance
on bacterial culture to identify organisms, which may underestimate bacterial prevalence and the inability
to subtype organisms. However, the four most common bacterial species identified are the major
contributors to bacterial LRTI in infants. In addition to these species, we also identified a range of
gram-negative enteric bacterial species in the nasopharynx, but at a considerably lower frequency, and with
insufficient statistical power to draw conclusions. Gram-negative bacteria are important causes of LRTIs in
early life, particularly in the neonates [43]. It is unclear whether nasopharyngeal carriage with
gram-negative bacilli precedes invasive disease. Further work is required to understand the relationship
between environmental exposures, colonisation with gram-negative bacteria and LRTIs in early life.
Although standard bacterial culture is likely to miss key components of the bacterial microbiota of the
nasopharynx, one of the major advantages of culture over 16S-amplicon sequencing based microbiome
studies, is the ability to identify bacteria at the species level [44]. This is highly relevant for nasopharyngeal
bacteria, where there is substantial difference in potential for pathogenicity within a genus. Further, a
range of viral infections are likely to impact carriage of bacteria in the nasopharynx [45], with viral
infections playing a mediator role. IAP or ETS exposure may also impact on viral infections [46], which in
turn may influence bacterial carriage. However, a limitation of this study is that comprehensive assessment
of viral infections at a range of time points, including time points preceding our analysis of bacterial
carriage was beyond the scope of this analysis. Further, we considered multiple hypotheses at once through
multiple statistical tests. While we corrected for multiplicity using the Benjamini–Hochberg procedure, it is
a conservative procedure with the consequence that some of the significant associations might still be due
to chance. Strengths of this study were the large sample size, high cohort retention, longitudinal
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measurements of nasopharyngeal carriage, direct measurements of IAP both antenatally and postnatally,
testing of maternal and infant samples and comprehensive analysis which considered numerous covariates.
The association between both IAP and ETS exposure on maternal and infant nasopharyngeal bacterial
carriage has not been well described, particularly in LMICs and peri-urban communities who may rely on
alternate fuel sources. This study highlights the need for effective, preventative measures to reduce such
exposures. The population in this study represent a particularly vulnerable group of poor pregnant women
and children in a LMIC setting, where there is a high burden of respiratory disease. Effective strategies to
reduce smoking in pregnant women and to minimise household IAP exposure from both alternate fuel
sources and ETS exposure are needed to improve child and maternal health particularly in LMICs.
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